LEO Pharma, founded in 1908, is an independent research-based pharmaceutical company. Today, LEO Pharma develops, produces, and distributes pharmaceutical products to cure thrombosis and dermatology-related issues in over 100 countries across the globe. LEO Pharma’s vision is to be the preferred dermatology care partner and improve people’s lives around the world. LEO Pharma in Russia, registered as a legal entity of LEO Pharmaceutical Products LLC, was founded in August 2013.
The management of LEO Pharmaceutical Products LLC decided to introduce the 1C-Rarus: Financial Management 3 software of the 1C:Enterprise 8 system with the objective of the accounting automation.
A timely developer support and update of the system, which allows keeping records in full compliance with the current legislation, played an important role in choosing the software.
LEO Pharma chose 1C-Rarus to be the project partner due to the Company's immense experience in automation of accounting systems and also for having a quality management system certificate ISO 9001:2015.
The implementation of the software resulted in automating the accounting and tax accounting, according to international standards:
- Bank and cash registry,
- Settlements with counterparties,
- Inventory,
- Trading activities,
- Fixed assets,
- Intangible assets,
- Payroll and HR records,
- Period-end closing,
- Regulated reporting,
- Tax accounting,
- IFRS accounting.
During the project, the following works have been performed by the 1C-Rarus specialists:
- The software has been installed on the customer’s computers.
- Collection and analysis of customer requirements for the automated system.
- Methodological support and technical implementation of the specific accounting features have been completed.
- Interfaces and sets of user rights have been created.
- The new system has been integrated with the Trade Management configuration.
- The new system has been integrated with third-party automation systems.
- The program has been set up to start the process of accounting.
- Help entry of initial balances has been provided.
- Data from previous automation systems have been transferred.
- The staff was trained to work with the program.
The introduction of a new accounting system has increased the speed of the document workflow. Furthermore, the developed IFRS module is allowing employees to quickly receive the created postings, by the international standards. Thanks to the integration of all financial services, it became possible to control the financial results of the Company.
Industries
Products
1С-Rarus:Finance Management 3. Budgeting + IFRS Main delivery
Office
1С-Rarus Moscow
The number of ARM
6
Client cities
Moscow
Thanks for the introduction
Customer Testimonial
Founded in 1908, LEO Pharma is an independent, research-based pharmaceutical company. LEO Pharma develops,
manufactures and markets products for dermatology, bone remodeling thrombosis and coagulation in more than 100 world
countries. LEO Pharma aims to be a partner of choice for the dermatology community and improve the quality of life of
many people around the world.
In Russia LEO Pharma was founded in August 2003 as a legal entity OOO LEO Pharmaceuticals Products (LLC).
To automate accounting, the LEO Pharmaceuticals Products top management took a decision to implement 1C-Rarus:
Financial Management 3 belonging to the 1C-Enterprise 8 software family.
The first line support provided by the software developers, as well as software update that allowed keeping records
according to the current legislation played the crucial role for the software selection.
LEO Pharmaceuticals Products selected 1C-Rarus as a systems integrator as a highly professional and reliable partner
with vast experience in the sphere of accounting system automation, being certified under ISO 9001:2015 management
quality system.
Software implementation allowed the Company to automate financial and tax accounting, accounting under international
standards:
- Bank and cash;
- Settlements with counterparties;
- Commodities and materials;
- Trading transactions;
- Fixed assets;
- Intangible assets;
- Payroll and HR management;
- Period-end closing;
- Regulated accounting;
- Tax accounting;
- Accounting under IFRS.
Within the project, 1C-Rarus specialists performed the following:
- installed the software on customer's PCs;
- collected and analyzed customer’s requirements to the automated system;
- provided methodological support and technical implementation of accounting specifics;
- created interfaces and user permission sets;
- integrated the system with 1C:Trade Management;
- integrated the system with third-party software;
- adjusted software to start keeping accounting records;
- provided assistance in entering initial balances;
- transferred data from preceding automation systems;
- and trained staff on how to use the software.
6 workstations were automated. The system went live on 01.01.2020.
Implementation of the new accounting system allowed the Company to increase the document posting pace, the developed
IFRS module let promptly generate postings under international standards. As a result of the integration of all
financial services, the Company can control its financial result.
We express gratitude to 1C-Rarus for our mutually beneficial collaboration and qualified service provided for the task
solution. It is a great pleasure to work with highly experienced specialists who can provide professional services at
the top level.
5-point scale rating of the implemented information system
according to the following parameters:
Compliance with the company’s needs (Where 5 means that all required features have
been implemented in the information system)
Convenience of the system operation (Where 5 means that it is easy and convenient)
Rate the work quality of the 1C Partner (Where 5 means that you are satisfied with the
Partner’s work)
Would you recommend this solution to your colleagues to use it for the automation of
their business activities? (Choose one from the list)
Confirmation of 1С:Enterprise Implementation
Automating accounting based on 1C-Rarus:Financial Managemenet 3 at LEO
Pharmaceuticals Products LLC
Customer:
LEO Pharmaceuticals Products LLC
Branch, business activity:
Trade, warehouse, logistics, transport >> Trade >>
Medication
Type of trading activity:
Wholesale distribution
City/Town/Locality:
Moscow
Implementation done by 1С Partner:
1C-Rarus
We hereby confirm the implementation of the following
standard 1С:Enterprise solution(s) in our company:
1С-Rarus:Finance Management 3
Completed the following work:
- Consulting on software selection and support options.
- Sale of software products selected.
- Software delivery to the customer's office.
- Software installation on customer's PCs.
- Collection and analysis of customer's requirements to the automated system.
- Methodological support and technical implementation of management and accounting
specifics in the system (requirements to the customization): 1C-Rarus specialists adjusted the standard system
according to the customer's requirements.
- Creating interfaces and user permission sets.
- Integration with other systems based on 1C:Enterprise.
- Integration with third-party software.
- Initial settings of standard/business app to start keeping records.
- Entering opening balances / assistance in entering balances.
- Data migration from preceding systems.
Functions automated:
- Accounting according to international and national standards.
- Accounting under International Standards.
- Accounting under IFRS.
- Finance, management accounting, performance monitoring.
- Financial, tax, and budgetary accounting including regulatory statements:
- Accounting:
- Bank and cash;
- Period-end closing;
- Intangible assets;
- Fixed assets;
- Payroll calculation and HR management;
- Settlements with counterparties;
- Regulatory accounting;
- Inventory items;
- Trading activities.
- Tax accounting.
Work options:
Client-Server
Quantity of automated workstations:
6
Quantity of concurrent users:
"Thin" client: 6
Additional information about software implementation:
Founded in 1908, LEO Pharma is an independent, research-based pharmaceutical
company. LEO Pharma develops, manufactures and markets products for dermatology, bone remodeling thrombosis and
coagulation in more than 100 world countries.
LEO Pharma aims to be a partner of choice for the dermatology community and
improve the quality of life of many people around the world.
In Russia LEO Pharma was founded in August 2003 as a legal entity OOO LEO
Pharmaceuticals Products (LLC).
To automate accounting, the LEO Pharmaceuticals Products top management took a
decision to implement 1C-Rarus: Financial Management 3 belonging to the 1C-Enterprise 8 software family.
The first line support provided by the software developer as well as software
update that allowed keeping records according to the current legislation played the crucial role for the
software selection.
1C-Rarus being highly experienced in the automation of accounting systems was
involved as a system integrator ISO 9001:2015 certified.
Software implementation allowed the Company to automate financial and tax
accounting, accounting under international standards:
- Bank and cash;
- Settlements with counterparties;
- Commodities and materials;
- Trading transactions;
- Fixed assets;
- Intangible assets;
- Payroll and HR management;
- Period-end closing;
- Regulated accounting;
- Tax accounting;
- Accounting under IFRS.
Within the project, 1C-Rarus specialists performed the following:
- installed the software on customer's PCs;
- collected and analyzed customer’s requirements to the automated system;
- provided methodological support and technical implementation of accounting
specifics;
- created interfaces and user permission sets;
- integrated the system with 1C:Trade Management;
- integrated the system with third-party software;
- adjusted software to start keeping accounting records;
- provided assistance in entering initial balances;
- transferred data from preceding automation systems;
- and trained staff on how to use the software.
Implementation of the new accounting system allowed the Company to increase
the document posting pace; the developed IFRS module let promptly generate postings under international
standards. As a result of the integration of all financial services, the Company can control its financial
result.
Information technology support (ITS):
- beneficial 1C:ITS support;
- web-version of ITS and ITS web-servers;
- consulting on procedure issues of work with 1C;
- consulting on technical issues on 1C use.
Additional information about the company to be posted
on the website:
Founded in 1908, LEO Pharma is an independent, research-based pharmaceutical
company.
LEO Pharma develops, manufactures and markets products for dermatology, bone
remodeling thrombosis and coagulation in more than 100 world countries. LEO Pharma aims to be a partner of
choice for the dermatology community and improve the quality of life of many people around the world.
In Russia LEO Pharma was founded in August 2003 as a legal entity OOO LEO
Pharmaceuticals Products (LLC).
Galaburda I.V., General Director
23.11.2020
